SCHEMBL10075708

SCHEMBL10075708

CC(=O)O/N=C(\C)C(=O)c1ccc(Sc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 1/20 0.44
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 1/20 0.43
RXRA P19793 2/20 0.40
RXRB P28702 2/20 0.40
RXRG P48443 2/20 0.40
RARB P10826 1/20 0.40
RARG P13631 1/20 0.40
HSD17B10 Q99714 1/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
KDM4E B2RXH2 3/20 0.38
APEX1 P27695 1/20 0.38
TSHR P16473 2/20 0.36
TP53 P04637 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20935148 0.94 L3MBTL1 (0.50) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL16019156 0.91 HPGD (0.56) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL19795435 0.91 HPGD (0.56) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL24489413 0.88 L3MBTL1 (0.44) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL19795439 0.88 L3MBTL1 (0.57) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL10075752 0.88 LMNA (0.44) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL20709734 0.86 L3MBTL1 (0.40) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL10075729 0.84 KDM4E (0.38) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL19751020 0.84 L3MBTL1 (0.41) HPGDL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL10075765 0.83 TSHR (0.38) HPGDL3MBTL1LMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023176899-A1 PHOTOSENSITIVE RESIN COMPOSITION, PIGMENT DISPERSION, CURED PRODUCT, BLACK MATRIX, AND IMAGE DISPLAY DEVICE 三菱ケミカル株式会社 2023-09-21 WO disclosed
WO-2023176898-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, BLACK MATRIX, AND IMAGE DISPLAY DEVICE 三菱ケミカル株式会社 2023-09-21 WO disclosed
WO-2023068201-A1 PIGMENT DISPERSION, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, BLACK MATRIX, AND IMAGE DISPLAY DEVICE 三菱ケミカル株式会社 2023-04-27 WO disclosed
WO-2022091951-A1 METHOD FOR PRODUCING CARBOXY-GROUP-CONTAINING RESIN AND METHOD FOR CONTROLLING MOLECULAR WEIGHT OF CARBOXY-GROUP-CONTAINING RESIN 三菱ケミカル株式会社 2022-05-05 WO disclosed
EP-2586827-B1 CURABLE RESIN COMPOSITION ADEKA CORP (JP) 2017-12-27 EP disclosed
US-8735511-B2 Curing resin composition ADEKA CORPORATION (JP) 2014-05-27 US disclosed
US-8735511-B2 Curing resin composition ADEKA CORPORATION (JP) 2014-05-27 US disclosed
EP-2586827-A1 CURABLE RESIN COMPOSITION Adeka Corporation (JP) 2013-05-01 EP disclosed
US-20120115972-A1 CURING RESIN COMPOSITION ADEKA CORPORATION (JP) 2012-05-10 US disclosed
US-20120115972-A1 CURING RESIN COMPOSITION ADEKA CORPORATION (JP) 2012-05-10 US disclosed
US-8148045-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2012-04-03 US disclosed
US-8148045-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2012-04-03 US disclosed
EP-2327689-B1 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORP (JP) 2012-02-29 EP disclosed
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-02 US disclosed
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-02 US disclosed
EP-2327689-A1 Oxime ester compound and photopolymerization initiator containing the same Adeka Corporation (JP) 2011-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME OXER1, OR10J3, CDK11B HPGD 1805/4885L3MBTL1 1628/4885LMNA 3014/4885
US-20120115972-A1 CURING RESIN COMPOSITION LTA, LOXL1, PLOD2 HPGD 654/4885L3MBTL1 228/4885LMNA 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.